175 related articles for article (PubMed ID: 16311409)
21. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.
Prezant TR; Levine J; Melmed S
J Clin Endocrinol Metab; 1998 Apr; 83(4):1388-91. PubMed ID: 9543172
[TBL] [Abstract][Full Text] [Related]
23. Familial pituitary tumors.
Alband N; Korbonits M
Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
[TBL] [Abstract][Full Text] [Related]
24. Genetics of pituitary adenomas.
Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
[TBL] [Abstract][Full Text] [Related]
25. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
26. GNAS imprinting and pituitary tumors.
Mantovani G; Lania AG; Spada A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):15-8. PubMed ID: 20398730
[TBL] [Abstract][Full Text] [Related]
27. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.
Moreno CS; Evans CO; Zhan X; Okor M; Desiderio DM; Oyesiku NM
Cancer Res; 2005 Nov; 65(22):10214-22. PubMed ID: 16288009
[TBL] [Abstract][Full Text] [Related]
28. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
29. Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas.
Chamaon K; Kanakis D; Mawrin C; Dietzmann K; Kirches E
Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):121-6. PubMed ID: 19472104
[TBL] [Abstract][Full Text] [Related]
30. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
Ruebel KH; Leontovich AA; Jin L; Stilling GA; Zhang H; Qian X; Nakamura N; Scheithauer BW; Kovacs K; Lloyd RV
Endocrine; 2006 Jun; 29(3):435-44. PubMed ID: 16943582
[TBL] [Abstract][Full Text] [Related]
31. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis.
Ezzat S; Zheng L; Zhu XF; Wu GE; Asa SL
J Clin Invest; 2002 Jan; 109(1):69-78. PubMed ID: 11781352
[TBL] [Abstract][Full Text] [Related]
32. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
[TBL] [Abstract][Full Text] [Related]
33. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
34. Genesis of pituitary adenomas: state of the art.
Faglia G; Spada A
J Neurooncol; 2001 Sep; 54(2):95-110. PubMed ID: 11761437
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
D'Abronzo FH; Swearingen B; Klibanski A; Alexander JM
J Clin Endocrinol Metab; 1999 May; 84(5):1716-21. PubMed ID: 10323406
[TBL] [Abstract][Full Text] [Related]
36. 11q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1.
Weil RJ; Vortmeyer AO; Huang S; Boni R; Lubensky IA; Pack S; Marx SJ; Zhuang Z; Oldfield EH
Clin Cancer Res; 1998 Jul; 4(7):1673-8. PubMed ID: 9676841
[TBL] [Abstract][Full Text] [Related]
37. A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus.
Bossis I; Voutetakis A; Matyakhina L; Pack S; Abu-Asab M; Bourdeau I; Griffin KJ; Courcoutsakis N; Stergiopoulos S; Batista D; Tsokos M; Stratakis CA
J Med Genet; 2004 Aug; 41(8):596-600. PubMed ID: 15286154
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of galectin-3 in pituitary tumors.
Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
[TBL] [Abstract][Full Text] [Related]
39. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).
Pack SD; Kirschner LS; Pak E; Zhuang Z; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2000 Oct; 85(10):3860-5. PubMed ID: 11061550
[TBL] [Abstract][Full Text] [Related]
40. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
